AQR Arbitrage’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-17,235
Closed -$5.51K – 912
2023
Q1
$5.51K Sell
17,235
-29,207
-63% -$6.86K ﹤0.01% 940
2022
Q4
$2.3K Sell
46,442
-3,554
-7% -$423 ﹤0.01% 1111
2022
Q3
$6K Hold
49,996
– – ﹤0.01% 1226
2022
Q2
$8K Hold
49,996
– – ﹤0.01% 1261
2022
Q1
$10K Buy
+49,996
New +$11.9K ﹤0.01% 1255

Other funds holding CDIOW

AQR Arbitrage's CDIOW Position: Q2 2023 in Review

AQR Arbitrage sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q2 2023, closing a stake of 17,235 shares — an estimated $5.51K sold.

AQR Arbitrage first reported a position in CDIOW in Q1 2022 and held it in 5 quarters. The position peaked at $10K in Q1 2022. 13 funds tracked by Wall St. Rank hold CDIOW as of Q2 2023.

  • AQR Arbitrage reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • AQR Arbitrage sold 17,235 Cardio Diagnostics Holdings Inc Warrant shares in Q2 2023, an estimated $5.51K.
  • AQR Arbitrage first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 5 quarters.
  • AQR Arbitrage's Cardio Diagnostics Holdings Inc Warrant position peaked at $10K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.